Position in LLY
as of Jun 30, 2026
· filed Aug 12, 2026
Position Value
$207,952,392
-$123,290,815 QoQ
Shares Held
173,376
-51.9% QoQ
Ownership
0.018%
of shares outstanding
% of Portfolio
0.35%
of 13F equity value
Holder Rank
#261
of 4,605 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Derivatives in LLY
reported options exposure · as of Jun 30, 2026CallValue
$0
CallShares
0
PutValue
$131,937
PutShares
110
Notional value of option positions as reported on Form 13F. Calls and puts are disclosed separately and do not net against the common-share stake above.
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026BANK OF NOVA SCOTIA holds $1,312,781,180 across 10 Drug Manufacturers - General names. LLY ranks #3 (15.8% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRK |
Merck & Co., Inc.
|
2,191,725 | $281,636,662 | |
| 2 | JNJ |
Johnson & Johnson
|
886,454 | $225,132,721 | |
| 3 | LLY |
ELI LILLY & Co
This page
|
173,376 | $207,952,392 | |
| 4 | NVO |
Novo Nordisk A S
|
3,065,015 | $146,936,818 | |
| 5 | PFE |
Pfizer Inc
|
4,423,296 | $106,512,967 | |
| 6 | GILD |
Gilead Sciences, Inc.
|
791,956 | $100,055,721 | |
| 7 | BMY |
Bristol Myers Squibb Co
|
1,726,026 | $99,453,618 | |
| 8 | ABBV |
AbbVie Inc.
|
337,881 | $85,024,374 |
All Filings in LLY
Export CSV
29 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $131,937 | 110 | Put | Defined | 2026-08-12 | |
| 2026-06-30 | $207,952,392 | 173,376 | Shares | Sole | 2026-08-12 | |
| 2026-03-31 | $331,243,207 | 360,137 | Shares | Sole | 2026-05-14 | |
| 2025-12-31 | $134,335 | 125 | Put | Defined | 2026-02-13 | |
| 2025-12-31 | $369,994,086 | 344,283 | Shares | Defined | 2026-02-13 | |
| 2025-09-30 | $254,310,952 | 333,304 | Shares | Defined | 2025-11-14 | |
| 2025-09-30 | $499,002 | 654 | Put | Defined | 2025-11-14 | |
| 2025-06-30 | $193,526,117 | 248,260 | Shares | Defined | 2025-08-13 | |
| 2025-03-31 | $203,903,963 | 246,884 | Shares | Defined | 2025-07-02 | |
| 2024-12-31 | $282,866,204 | 366,407 | Shares | Defined | 2025-07-02 | |
| 2024-09-30 | $167,067,020 | 188,576 | Shares | Sole | 2024-11-13 | |
| 2024-06-30 | $215,927,697 | 238,494 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $140,230,400 | 180,254 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $291,708,904 | 500,427 | Shares | Defined | 2024-02-12 | |
| 2023-09-30 | $146,145,550 | 272,086 | Shares | Defined | 2023-11-14 | |
| 2023-06-30 | $114,364,524 | 243,858 | Shares | Defined | 2023-08-03 | |
| 2023-03-31 | $34,420,986 | 100,230 | Shares | Defined | 2023-05-11 | |
| 2022-12-31 | $72,847,157 | 199,123 | Shares | Defined | 2023-02-09 | |
| 2022-09-30 | $50,506,946 | 156,199 | Shares | Sole | 2022-11-10 | |
| 2022-06-30 | $63,408,363 | 195,566 | Shares | Sole | 2022-08-11 | |
| 2022-03-31 | $112,272,216 | 392,053 | Shares | Defined | 2022-05-09 | |
| 2021-12-31 | $46,567,100 | 168,587 | Shares | Defined | 2022-02-11 | |
| 2021-09-30 | $32,788,997 | 141,913 | Shares | Sole | 2021-11-12 | |
| 2021-06-30 | $30,567,014 | 133,178 | Shares | Defined | 2021-08-12 | |
| 2021-03-31 | $46,146,406 | 247,010 | Shares | Sole | 2021-05-06 | |
| 2020-12-31 | $46,494,989 | 275,379 | Shares | Defined | 2021-02-11 | |
| 2020-09-30 | $159,298,087 | 1,076,193 | Shares | Defined | 2020-11-12 | |
| 2020-06-30 | $79,966,823 | 487,068 | Shares | Defined | 2020-08-11 | |
| 2020-03-31 | $99,644,794 | 718,316 | Shares | Defined | 2020-05-15 | |
| No filing history on record for this holder in this stock. | ||||||